SCHEMBL2939442

SCHEMBL2939442

CC(C)OC(=O)N1CCC(C(=O)NNC(=O)C2CCN(C(=O)OC(C)(C)C)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
HPGD P15428 1/20 0.52
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN6 P29350 1/20 0.49
RECQL P46063 1/20 0.47
EPHX1 P07099 1/20 0.47
ABL1 P00519 1/20 0.46
RIN1 Q13671 1/20 0.46
EPHX2 P34913 2/20 0.44
STS P08842 6/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GPR119 Q8TDV5 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2939443 1.00 KMT2A (0.54) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL2282144 0.84 KMT2A (0.55) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL16400521 0.83 KMT2A (0.67) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL2146474 0.81 HPGD (0.57) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL12069934 0.81 KMT2A (0.58) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL15084776 0.79 HPGD (0.57) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL18987390 0.79 HPGD (0.57) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL12513264 0.79 KMT2A (0.62) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL13798748 0.79 HPGD (0.57) KMT2AHPGDPTPN2PTPN1PTPN6
SCHEMBL19786045 0.79 USP2 (0.55) KMT2AHPGDRECQLEPHX1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134704-B1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-09-22 EP disclosed
US-20100120807-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-05-13 US disclosed
EP-2134704-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-12-23 EP disclosed
WO-2008109702-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120807-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 KMT2A 3355/4885HPGD 1541/4885PTPN2 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.